TXG

Equibles Rating blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 15.8 · calm Equity put/call 0.57

Technical

price trend

Strong Buy

50 / 200-day cross No cross

Price vs 200-day avg +83%

above

Price vs 50-day avg +32%

above

RSI (14) 63

neutral

MACD trend Positive

52-week position 89%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +28%

trailing

6-month return +83%

trailing

YTD return +130%

this year

Relative strength +75%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $28 › 200d $21 — 50d above 200d

Institutional flow Accumulating

11 of 332 funds reported for Jun 30 · net +934 sh shares · +3 new

Insider flow Distributing

Net -$1.5M over 90 days · 100% sells

Short interest Rising

17.41% of float · ▲ +34.0% MoM · 6.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

332 holders — near 3-yr high, broad support

Squeeze score 64

elevated · 0–100

Fundamentals

Excellent

Revenue growth +68%

Y/Y

Gross margin 181%

contracting

EPS growth +77%

Y/Y

Free cash flow $130.1M

Balance sheet $314.3M

net cash

Quant / Vol

risk profile

Very High

Volatility 68%

annualized · 1-yr

Max drawdown −28%

past year

ATR 6.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next

Next earnings call

Aug 6, 2026 Est · unconfirmed · in 4 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 8, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Guidance & track record what management promised — and delivered

Latest guidance · from the 8-K filed May 7, 2026

Revenue · full year 2026 Initiated $600M – $625M

prior FY $642.82M midpoint −4.7% Y/Y

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy

0 · 3 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+83% Bullish

Price vs 50-day avg

+32% Bullish

RSI (14)

63 Neutral

MACD trend

Positive Bullish

52-week position

89% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $28 › 200d $21 — 50d above 200d

Institutional flow Accumulating

11 of 332 funds reported for Jun 30 · net +934 sh shares · +3 new

Insider flow Distributing

Net -$1.5M over 90 days · 100% sells

Short interest Rising

17.41% of float · ▲ +34.0% MoM · 6.8 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

332 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $11 Now $37 · 89% 52-wk high $41

vs 200-day avg +83% vs 50-day avg +32%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Gross margin	70%	Q1 2026	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Health Information Services — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
TXG 10x Genomics, Inc. this stock	$5.47B	+129.7%	+68.1%	—	17.4%
VEEV Veeva Systems Inc	$30.82B	-15.7%	+28.1%	33.6	4.6%
PMDIY Pro Medicus Ltd./ADR	$15.67B	-9.4%	—	—	0.0%
BTSG BrightSpring Health Services, Inc.	$13.88B	+88.3%	-0.4%	51.1	4.8%
TEM Tempus AI, Inc.	$11.04B	-3.0%	+65.8%	—	21.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

335

% held: 94.0%
Reported: 11 of 332
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

288

View

Short & Settlement

Short Interest Rising

Shares short

22.1M

Days to cover: 6.8d
Change: +5.6M sh

View

Short Volume

Short vol %

41%

As of: Jul 9, 2026

Short Total

View

Fails to Deliver

FTD shares

7.1K

Value: $205.6K
As of: Jun 12, 2026

View

Off-Exchange

Off-exchange %

44.6%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$1.5M

Buyers / Sellers: 0 / 3

Buyers Sellers

View

Financials

Revenue (FY)

$642.8M

Net income (FY): $-43.5M
EPS diluted: $-0.35

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 8, 2026
This year: 7

View

Proposed Sales

Value

$232.7K

Shares: 9.4K
Filed: May 22, 2026

View

Earnings & Events

Earnings Calls

Last call

May 7, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
TXG	-2.3%	+28.4%	+82.6%	-2.3%	+129.7%
SPY	-0.2%	+0.8%	+7.4%	-0.2%	+9.3%
vs SPY	-2.1%	+27.6%	+75.2%	-2.1%	+120.4%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance